Daniel M. Fass

4.2k total citations · 2 hit papers
35 papers, 2.8k citations indexed

About

Daniel M. Fass is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Daniel M. Fass has authored 35 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 10 papers in Genetics. Recurrent topics in Daniel M. Fass's work include Histone Deacetylase Inhibitors Research (13 papers), Genetics and Neurodevelopmental Disorders (8 papers) and Protein Degradation and Inhibitors (7 papers). Daniel M. Fass is often cited by papers focused on Histone Deacetylase Inhibitors Research (13 papers), Genetics and Neurodevelopmental Disorders (8 papers) and Protein Degradation and Inhibitors (7 papers). Daniel M. Fass collaborates with scholars based in United States, Germany and Slovakia. Daniel M. Fass's co-authors include Stephen J. Haggarty, Krista M. Hennig, Richard H. Goodman, Gavin Rumbaugh, J. David Sweatt, Mark Kilgore, Courtney A. Miller, Li‐Huei Tsai, Nadine F. Joseph and Jean‐René Cardinaux and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Daniel M. Fass

35 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An epigenetic blockade of cognitive functions in the neurodegenerating brain

2012 638 citations Johannes Gräff, Damien Rei et al. Nature profile →
Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease

2009 557 citations Mark Kilgore, Courtney A. Miller et al. Neuropsychopharmacology profile →

Peers

Countries citing papers authored by Daniel M. Fass

Since Specialization

Citations

This map shows the geographic impact of Daniel M. Fass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Fass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Fass more than expected).

Fields of papers citing papers by Daniel M. Fass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Fass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Fass. The network helps show where Daniel M. Fass may publish in the future.

Co-authorship network of co-authors of Daniel M. Fass

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Fass. A scholar is included among the top collaborators of Daniel M. Fass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Fass. Daniel M. Fass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Benzoxazole-derivatives enhance progranulin expression and reverse the aberrant lysosomal proteome caused by GRN haploinsufficiency 2024 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), Basar Cenik, (unknown), Jue Liang, Daniel M. Fass, Zachary P. Rosenthal, Stephen J. Haggarty, Noelle S. Williams, Bruce A. Posner, Joseph M. Ready, Joachim Herz	3
2	Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility 2022 ·Molecular Psychiatry ·Daniel M. Fass, Michael C. Lewis, Rushdy Ahmad, Matthew J. Szucs, Qiangge Zhang, (unknown), Dongqing Wang, Myung Jong Kim, Jonathan Biag, Steven A. Carr, Edward M. Scolnick, Richard T. Premont, Stephen J. Haggarty	7
3	Histone deacetylase knockouts modify transcription, CAG instability and nuclear pathology in Huntington disease mice 2020 ·eLife ·Marina Kovalenko, Serkan Erdin, (unknown), Jason St. Claire, (unknown), Leroy Hubert, (unknown), Alexei Stortchevoi, Daniel M. Fass, Ricardo Mouro Pinto, Stephen J. Haggarty, John H. Wilson, Michael E. Talkowski, Vanessa C. Wheeler	8
4	Kinetic Tuning of HDAC Inhibitors Affords Potent Inducers of Progranulin Expression 2019 ·ACS Chemical Neuroscience ·Carlos Moreno–Yruela, Daniel M. Fass, Chialin Cheng, Joachim Herz, Christian A. Olsen, Stephen J. Haggarty	21
5	Class I Histone Deacetylase Inhibition by Tianeptinaline Modulates Neuroplasticity and Enhances Memory 2018 ·ACS Chemical Neuroscience ·Wen‐Ning Zhao, Balaram Ghosh, Marshall Tyler, Jasmin Lalonde, Nadine F. Joseph, Nina Kosaric, Daniel M. Fass, Li‐Huei Tsai, Ralph Mazitschek, Stephen J. Haggarty	19
6	WNT/β-Catenin Pathway and Epigenetic Mechanisms Regulate the Pitt-Hopkins Syndrome and Schizophrenia Risk Gene TCF4 2017 ·PubMed ·Krista M. Hennig, Daniel M. Fass, Wen‐Ning Zhao, Steven D. Sheridan, Ting Fu, Serkan Erdin, Alexei Stortchevoi, Diane Lucente, Jannine D. Cody, David A. Sweetser, James F. Gusella, Michael E. Talkowski, Stephen J. Haggarty	21
7	Highly Expandable Human iPS Cell–Derived Neural Progenitor Cells (NPC) and Neurons for Central Nervous System Disease Modeling and High‐Throughput Screening 2017 ·Current Protocols in Human Genetics ·Chialin Cheng, Daniel M. Fass, Kat Folz‐Donahue, Marcy E. MacDonald, Stephen J. Haggarty	23
8	Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors 2016 ·Bioorganic & Medicinal Chemistry ·Florence F. Wagner, Michel Weïwer, Stefan Steinbacher, Adrian Schomburg, Peter Reinemer, Jennifer Gale, Arthur J. Campbell, Stewart L. Fisher, Wen‐Ning Zhao, Surya A. Reis, Krista M. Hennig, Méryl Thomas, Peter Müller, Martin R. Jefson, Daniel M. Fass, Stephen J. Haggarty, Yanling Zhang, Edward B. Holson	63
9	Automated Structure–Activity Relationship Mining: Connecting Chemical Structure to Biological Profiles 2014 ·SLAS DISCOVERY ·Mathias J. Wawer, David E. Jaramillo, Vlado Dančík, Daniel M. Fass, Stephen J. Haggarty, Alykhan F. Shamji, Bridget K. Wagner, Stuart L. Schreiber, Paul A. Clemons	17
10	A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests 2013 ·PLoS ONE ·Frederick A. Schroeder, Michael C. Lewis, Daniel M. Fass, Florence F. Wagner, Yanling Zhang, Krista M. Hennig, Jennifer Gale, Wen‐Ning Zhao, Surya A. Reis, Douglas Barker, (unknown), Sung Won Kim, Elizabeth L. Clore, Jacob M. Hooker, Edward B. Holson, Stephen J. Haggarty, Tracey L. Petryshen	105
11	An epigenetic blockade of cognitive functions in the neurodegenerating brain breakdown → 2012 ·Nature ·Johannes Gräff, Damien Rei, Ji‐Song Guan, Wenyuan Wang, Jinsoo Seo, Krista M. Hennig, Thomas J.F. Nieland, Daniel M. Fass, Patricia F. Kao, Martin C. Kahn, Susan C. Su, Alireza Samiei, Nadine F. Joseph, Stephen J. Haggarty, Ivana Delalle, Li‐Huei Tsai	638
12	The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells 2011 ·Cancer Biology & Therapy ·Andrew J. Wilson, Edward B. Holson, Florence F. Wagner, (unknown), Daniel M. Fass, Stephen J. Haggarty, Srividya Bhaskara, Scott W. Hiebert, Stuart L. Schreiber, Dineo Khabele	41
13	Chemical-Genetic Screen Identifies Riluzole as an Enhancer of Wnt/β-catenin Signaling in Melanoma 2010 ·Chemistry & Biology ·Travis L. Biechele, Nathan D. Camp, Daniel M. Fass, Rima M. Kulikauskas, (unknown), (unknown), (unknown), Erin Moore, Jeanot Muster, Rakesh Karmacharya, Stephen J. Haggarty, Andy J. Chien, Randall T. Moon	52
14	Short-Chain HDAC Inhibitors Differentially Affect Vertebrate Development and Neuronal Chromatin 2010 ·ACS Medicinal Chemistry Letters ·Daniel M. Fass, (unknown), Balaram Ghosh, Krista M. Hennig, Stephanie Norton, Wen‐Ning Zhao, Surya A. Reis, Peter S. Klein, Ralph Mazitschek, Rebecca L. Maglathlin, Timothy A. Lewis, Stephen J. Haggarty	74
15	Inhibitors of Class 1 Histone Deacetylases Reverse Contextual Memory Deficits in a Mouse Model of Alzheimer's Disease breakdown → 2009 ·Neuropsychopharmacology ·Mark Kilgore, Courtney A. Miller, Daniel M. Fass, Krista M. Hennig, Stephen J. Haggarty, J. David Sweatt, Gavin Rumbaugh	557
16	Deacetylase Activity Is Required for cAMP Activation of a Subset of CREB Target Genes 2003 ·Journal of Biological Chemistry ·Daniel M. Fass, (unknown), Richard H. Goodman	121
17	Phosphorylation of CBP Mediates Transcriptional Activation by Neural Activity and CaM Kinase IV 2002 ·Neuron ·Soren Impey, (unknown), Yanhong Wang, Jean‐René Cardinaux, Daniel M. Fass, Karl Obrietan, Gary A. Wayman, Daniel R. Storm, Thomas R. Soderling, Richard H. Goodman	282
18	Cooperative Mechanism of Transcriptional Activation by a Cyclic AMP-response Element Modulator α Mutant Containing a Motif for Constitutive Binding to CREB-binding Protein 2001 ·Journal of Biological Chemistry ·Daniel M. Fass, Johanna C. Craig, Soren Impey, Richard H. Goodman	9
19	Bay K 8644 reveals two components of L-type Ca2+ channel current in clonal rat pituitary cells. 1996 ·The Journal of General Physiology ·Daniel M. Fass, (unknown)	18
20	Current, voltage and pharmacological substrates of a novel GABA receptor in the visual-vestibular system of Hermissenda 1994 ·Brain Research ·D F Rogers, Daniel M. Fass, Louis D. Matzel	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact